JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258502

Human LRWD1 knockout HeLa cell lysate

Be the first to review this product! 리뷰 제출

|

(0 출판물)

LRWD1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.
2 이미지
Sanger Sequencing - Human LRWD1 knockout HeLa cell lysate (AB258502)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRWD1 knockout HeLa cell lysate (AB258502)

Allele-1 : 1 bp deletion in exon1

Sanger Sequencing - Human LRWD1 knockout HeLa cell lysate (AB258502)
  • Sanger seq

Unknown

Sanger Sequencing - Human LRWD1 knockout HeLa cell lysate (AB258502)

Allele-2 : Insertion of the selection cassette in exon1

주요 정보

세포 유형

HeLa

Species or organism

Human

조직

Cervix

Knockout 검증

Sanger Sequencing

Mutation 정보

Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon1 and Insertion of the selection cassette in exon1.

질병

Adenocarcinoma

제품 세부 정보

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

제품 구성

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258502-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human LRWD1 knockout HeLa cell lysate", "number":"AB258502-CMP02", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HeLa cell lysate", "number":"AB258502-CMP01", "productcode":"" } ] } } }

특성 및 보관 정보

유전자명
LRWD1
유전자 편집 종류
Knockout
유전자 편집 방식
CRISPR technology
Knockout 검증
Sanger Sequencing
배송 시 보관 조건
Ambient - Can Ship with Ice
적절한 단기 보관 조건
-20°C
적절한 장기 보관 조건
-20°C

추가 정보

This supplementary information is collated from multiple sources and compiled automatically.

The LRWD1 also known as Leucine-rich repeats and WD repeat-containing protein 1 plays an essential mechanical role in cells. This protein weighs approximately 63 kDa and is expressed mainly in tissues such as the testis. LRWD1 has structural domains that include leucine-rich repeats and WD repeat domains contributing to its role in protein interactions and signaling pathways.
Biological function summary

LRWD1 supports the regulation of DNA replication and centrosome cycle. It is an integral part of the DNA replication licensing pathway ensuring proper DNA synthesis during the cell cycle. By participating in this complex LRWD1 collaborates with proteins like CDC6 and CDT1 to initiate DNA replication. This protein ensures that cells duplicate their DNA once per cycle maintaining genomic stability.

Pathways

LRWD1 participates in the DNA replication pathway and is also linked to the G2 to M phase transition of the cell cycle. Through the DNA replication pathway LRWD1 works hand-in-hand with other factors such as ORC1 and MCM proteins which coordinate the licensing of replication origins. Its presence in these pathways demonstrates its pivotal role in maintaining normal cell cycle progression and genomic integrity.

LRWD1 has associations with disorders involving improper DNA replication and genome instability. Misregulation of this protein can relate to conditions such as cancer due to its involvement in cell cycle control. In cancer LRWD1's interaction with DNA replication-related proteins highlights the pathway's relevance in tumorigenesis. Researchers continue to investigate its role and potential connections to proteins like p53 which is frequently mutated in cancers.

품질 관리

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

제품 프로토콜

Product promise

저희는 고품질 시약으로 고객님의 연구를 서포트하고자 최선을 다하고 있으며, 모든 단계에서 함께 하겠습니다. 만약 제품이 기대한 성능을 보이지 않을 경우에도 Product Promise로 보호받으실 수 있습니다.
자세한 내용은 이용 약관을 확인해 주세요.

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com